These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9675482)

  • 1. Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar.
    Sundar S; Kumar P; Makharia M; Goyal A; Rogers M; Gibbs D; Murray H
    Clin Infect Dis; 1998 Jul; 27(1):215-6. PubMed ID: 9675482
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis.
    Murray HW; Hariprashad J
    Antimicrob Agents Chemother; 1996 Mar; 40(3):586-7. PubMed ID: 8851575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for use of atovaquone oral suspension in adult inpatients and outpatients.
    Goodwin SD; Fish DN
    Am J Health Syst Pharm; 1995 Nov; 52(21):2460-2. PubMed ID: 8564614
    [No Abstract]   [Full Text] [Related]  

  • 4. Ketoconazole in antimonial unresponsive cases of Kala-azar.
    Jha TK; Singh NK; Jha S
    J Assoc Physicians India; 1995 May; 43(5):347. PubMed ID: 9081966
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the activities of rifabutin combined with atovaquone or low-dose of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model.
    Brun-Pascaud M; Chau F; Rajagopalan-Levasseur P; Derouin F; Girard PM
    J Eukaryot Microbiol; 1996; 43(5):14S-15S. PubMed ID: 8822822
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluconazole in visceral leishmaniasis.
    Jha BB
    Indian Pediatr; 1998 Mar; 35(3):268-9. PubMed ID: 9707883
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis.
    Khalil EA; Nur NM; Zijlstra EE; El-Hassan AM; Davidson RN
    Trans R Soc Trop Med Hyg; 1996; 90(2):187-8. PubMed ID: 8761586
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
    Colakoglu M; Fidan Yaylali G; Yalcin Colakoglu N; Yilmaz M
    Scand J Infect Dis; 2006; 38(3):208-10. PubMed ID: 16500783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparasitic agent atovaquone.
    Baggish AL; Hill DR
    Antimicrob Agents Chemother; 2002 May; 46(5):1163-73. PubMed ID: 11959541
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
    Rybniker J; Goede V; Mertens J; Ortmann M; Kulas W; Kochanek M; Benzing T; Arribas JR; Fätkenheuer G
    Int J Infect Dis; 2010 Jun; 14(6):e522-5. PubMed ID: 19726213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
    Färnert A; Lindberg J; Gil P; Swedberg G; Berqvist Y; Thapar MM; Lindegårdh N; Berezcky S; Björkman A
    BMJ; 2003 Mar; 326(7390):628-9. PubMed ID: 12649236
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and management of Kala azar.
    Singh UK
    Indian Pediatr; 1999 Mar; 36(3):231-6. PubMed ID: 10713835
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of kala-azar with oral fluconazole.
    Sundar S; Singh VP; Agrawal NK; Gibbs DL; Murray HW
    Lancet; 1996 Aug; 348(9027):614. PubMed ID: 8774589
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluconazole plus allopurinol in treatment of visceral leishmaniasis.
    Torrús D; Boix V; Massa B; Portilla J; Pérez-Mateo M
    J Antimicrob Chemother; 1996 May; 37(5):1042-3. PubMed ID: 8737162
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases.
    Khandpur S; Chaturvedi P; Kumar U; Khaitan BK; Samantaray JC; Sharma VK
    Int J Dermatol; 2010 May; 49(5):565-9. PubMed ID: 20534094
    [No Abstract]   [Full Text] [Related]  

  • 17. Indian kala-azar--better tools needed for diagnosis and treatment.
    Sundar S
    J Postgrad Med; 2003; 49(1):29-30. PubMed ID: 12865568
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India.
    Thakur CP; Olliaro P; Gothoskar S; Bhowmick S; Choudhury BK; Prasad S; Kumar M; Verma BB
    Trans R Soc Trop Med Hyg; 1992; 86(6):615-6. PubMed ID: 1337634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
    Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
    Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambisome plus miltefosine for Indian patients with kala-azar.
    Sundar S; Sinha PK; Verma DK; Kumar N; Alam S; Pandey K; Kumari P; Ravidas V; Chakravarty J; Verma N; Berman J; Ghalib H; Arana B
    Trans R Soc Trop Med Hyg; 2011 Feb; 105(2):115-7. PubMed ID: 21129762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.